What is the recommended assessment and treatment protocol for pregnant patients with confirmed COVID-19, including vaccination, outpatient management, and hospital care?

COVID-19 in Pregnancy: Assessment and Treatment Protocol

Pregnant women with COVID-19 should receive the same diagnostic workup and treatments as non-pregnant patients, with modifications only for corticosteroid selection (use non-fluorinated glucocorticoids) and enhanced thromboprophylaxis, as pregnancy is not a contraindication to any COVID-19 therapy or supportive measure 1.

Vaccination

All pregnant women should be offered mRNA COVID-19 vaccination regardless of trimester 2, 3. The data are reassuring:

• mRNA vaccines show 95% efficacy after the second dose
• Cumulative spontaneous abortion risk of 14.1% among vaccinated pregnant women (6-19 weeks gestation) falls within the expected range for recognized pregnancies 2
• Immunogenicity, safety, and tolerability in pregnancy are comparable to non-pregnant women of the same age 4
• ACOG recommends vaccines should not be withheld from pregnant or lactating individuals who meet vaccination criteria 2

Risk Stratification

Pregnant women face increased susceptibility to severe COVID-19, particularly in the third trimester 5:

• Higher rates of hospitalization, ICU admission, and mechanical ventilation compared to non-pregnant peers 2
• Increased mortality, myocardial infarction, venous thromboembolism, pre-eclampsia, and preterm birth 2
• The hypercoagulable state of pregnancy is exacerbated by COVID-19's ACE2 receptor downregulation, increasing vascular dysfunction 2

After 28 weeks gestation, stringent social distancing should be observed 5.

Outpatient Management

Antenatal Care Modifications

• Reduce routine visit frequency at the discretion of the maternity unit for low-risk, uninfected women 5
• Utilize telemedicine services actively for non-urgent appointments 6
• Combine prenatal tests in single visits to minimize exposure 6
• Suspend carbon monoxide monitoring 5

For Confirmed COVID-19 Cases

• Refer to ultrasound for fetal growth surveillance 14 days after symptom resolution 5
• Self-isolation per national guidelines 5
• Consider differentials: pulmonary embolism and sepsis are critical mimics 5

Mental Health and Safeguarding

• Inquire about mental health at every consultation 5
• Maintain usual safeguarding referrals despite assessment challenges 5

Hospital Management

Thromboprophylaxis

Low molecular weight heparin prophylaxis is essential given the compounded thrombotic risk from both pregnancy and COVID-19 5, 1. Refer to full guidelines for specific dosing circumstances.

Pharmacological Treatment

Modify standard COVID-19 treatment protocols as follows 1:

• Corticosteroids: Use non-fluorinated glucocorticoids (prednisolone, methylprednisolone) instead of dexamethasone in critically ill pregnant women 1, 7
• IL-6 inhibitors and monoclonal antibodies: May be considered 1
• Specific antiviral therapies: May be used 1
• Radiology investigations: Perform without delay; fetal welfare concerns should not prevent necessary imaging 5

Respiratory Support

Pregnancy is NOT a contraindication to any respiratory support modality 1:

• Oxygen supplementation
• Non-invasive ventilation
• Awake prone positioning
• Intubation and mechanical ventilation (including prone positioning)
• Extracorporeal membrane oxygenation (ECMO)

Criteria for escalation are identical to the general population 1.

Intrapartum Care

Labor Management

• Continuous electronic fetal monitoring is mandatory for all suspected or confirmed COVID-19 cases 5
• One asymptomatic support person (no symptoms for 7 days) may be present 5
• Nitrous oxide (Entonox) with single-patient microbiological filter is safe—it is not an aerosol-generating procedure 5
• Avoid birthing pools in suspected/confirmed cases 5

Delivery Decisions

Timing, place, and mode of delivery require multidisciplinary team discussion including obstetricians, physicians, anesthetists, and intensivists experienced in COVID-19 pregnancy care 1:

• No specific mode of birth is indicated by COVID-19 status alone 5
• Cesarean delivery should follow standard obstetric indications 8
• Steroids for fetal lung maturation should be administered per routine protocols 5

Anesthesia

Neuraxial anesthesia should be favored over general anesthesia for labor and cesarean section unless contraindicated by patient status 4.

Personal Protective Equipment

Healthcare providers must wear appropriate PPE when treating suspected/confirmed cases; warn women and families early that obstetric emergencies may experience delays due to PPE donning 5.

Postnatal Care

• Discharge on postpartum day 1-2 depending on delivery mode 6
• Breastfeeding is recommended with protective equipment (mask, hand hygiene)—benefits outweigh neonatal infection risks 6, 8

Critical Pitfalls to Avoid

1. Do not withhold investigations or treatments due to unfounded fetal concerns—pregnant women are frequently denied necessary care 1
2. Do not delay imaging for pulmonary embolism or other emergencies 5
3. Do not use fluorinated corticosteroids (dexamethasone)—switch to prednisolone or methylprednisolone 1
4. Do not apply different respiratory support criteria—use the same thresholds as non-pregnant patients 1

The evidence consistently emphasizes that pregnancy should not limit access to standard COVID-19 care, with only minor modifications for specific medications 1, 4.